本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Atrium Therapeutics

10.06
-0.1500-1.47%
成交量:24.80萬
成交額:245.72萬
市值:1.72億
市盈率:-2.61
高:10.21
開:10.21
低:9.62
收:10.21
52周最高:16.77
52周最低:9.62
股本:1,710.56萬
流通股本:1,572.10萬
量比:0.37
換手率:1.58%
股息:- -
股息率:- -
每股收益(TTM):-3.8578
每股收益(LYR):-3.1905
淨資產收益率:-43.98%
總資產收益率:-399.25%
市淨率:0.80
市盈率(LYR):-3.15

資料載入中...

2024/12/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/15

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/12

重要事件披露

Form 8-K - Current report
2024/11/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/11/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/16

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/03

重要事件披露

Form 8-K - Current report
2024/10/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities